Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Article in BMC Medicine (October 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in BMC Medicine (October 2023)
Article in Marine Drugs (August 2023)